More Chemotherapy Does Not Obviate the Need for Radiation Therapy (RT): Treatment for Early-Stage Favorable Hodgkin Lymphoma According to the HD10 Trial Compared With Chemotherapy Alone

被引：1
|
作者：
Pinnix, C. C. [1 ]
Abou Yehia, Z. [1 ]
Smith, G. L. [1 ]
Milgrom, S. A. [1 ]
Ho, J. C. [1 ]
Reddy, J. [1 ]
Gunther, J. R. [2 ]
Akhtari, M. [1 ]
Osborne, E. M. [1 ]
Medeiros, L. J. [1 ]
Fanale, M. [1 ]
Dabaja, B. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.1858
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3203
引用
收藏
页码：E489 / E490
页数：2
相关论文
共 50 条
  • [31] Prognostic value of baseline metabolic tumor volume (MTV) for forecasting chemotherapy outcome in early-stage unfavorable Hodgkin lymphoma: Data from the phase III HD17 trial
    van Heek, Lutz
    Weindler, Jasmin
    Gorniak, Claudia
    Kaul, Helen
    Mueller, Horst
    Mettler, Jasmin
    Baues, Christian
    Fuchs, Michael
    Borchmann, Peter
    Ferdinandus, Justin
    Dietlein, Markus
    Voltin, Conrad-Amadeus
    Kobe, Carsten
    Roth, Katrin S.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (06) : 881 - 887
  • [32] Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma
    Cutter, David J.
    Ramroth, Johanna
    Diez, Patricia
    Buckle, Andy
    Ntentas, Georgios
    Popova, Bilyana
    Clifton-Hadley, Laura
    Hoskin, Peter J.
    Darby, Sarah C.
    Radford, John
    Illidge, Tim
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (32) : 3591 - +
  • [33] Final Analysis of a Randomized Comparison of ABVD Chemotherapy with a Strategy That Includes Radiation Therapy (RT) in Patients with Limited-Stage Hodgkin Lymphoma (HL): NCIC CTG/ECOG HD.6
    Meyer, Ralph M.
    Gospodarowicz, Mary
    Connors, Joseph M.
    Pearcey, Robert G.
    Wells, Woodrow A.
    Winter, Jane N.
    Horning, Sandra J.
    Dar, A. Rashid
    Shustik, Chaim
    Stewart, Douglas A.
    Crump, Michael
    Djurfeldt, Marina S.
    Chen, Bingshu E.
    Shepherd, Lois E.
    BLOOD, 2011, 118 (21) : 271 - 272
  • [34] Two cycles of ABVD followed by involved field radiotherapy with 20 Gray (Gy) is the new standard of care in the treatment of patients with early-stage Hodgkin lymphoma: final analysis of the randomized German Hodgkin Study Group (GHSG) HD10 study
    Engert, A.
    Diehl, V
    Pluetschow, A.
    Eich, H.
    Herrmann, R.
    Doerken, B.
    Kanz, L.
    Greil, R.
    Markova, J.
    Fuchs, M.
    Borchmann, P.
    Mueller-Hermeling, H. K.
    Mueller, R. P.
    ONKOLOGIE, 2010, 33 : 124 - 124
  • [35] TWO CYCLES OF ABVD FOLLOWED BY INVOLVED FIELD RADIOTHERAPY WITH 20 GRAY (GY) IS THE NEW STANDARD OF CARE IN THE TREATMENT OF PATIENTS WITH EARLY-STAGE HODGKIN LYMPHOMA: FINAL ANALYSIS OF THE RANDOMIZED GERMAN HODGKIN STUDY GROUP (GHSG) HD10 STUDY
    Engert, A.
    Pluetschow, A.
    Eich, H.
    Herrmann, R.
    Doerken, B.
    Kanz, L.
    Greil, R.
    Markova, J.
    Fuchs, M.
    Borchmann, P.
    Mueller-Hermelink, H.
    Mueller, R.
    Diehl, V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 473 - 473
  • [36] Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma:: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group
    Engert, A
    Schiller, P
    Josting, A
    Herrmann, R
    Koch, P
    Sieber, M
    Boissevain, F
    de Wit, M
    Mezger, J
    Dühmke, E
    Willich, N
    Müller, RP
    Schmidt, BF
    Renner, H
    Müller-Hermelink, HK
    Pfistner, B
    Wolf, J
    Hasenclever, D
    Löffler, M
    Diehl, V
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (19) : 3601 - 3608
  • [37] RADIATION-THERAPY VERSUS COMBINATION CHEMOTHERAPY IN THE TREATMENT OF EARLY-STAGE HODGKINS-DISEASE - 7-YEAR RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL
    LONGO, DL
    GLATSTEIN, E
    DUFFEY, PL
    YOUNG, RC
    HUBBARD, SM
    URBA, WJ
    WESLEY, MN
    RAUBITSCHEK, A
    JAFFE, ES
    WIERNIK, PH
    DEVITA, VT
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (06) : 906 - 917
  • [38] Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) is the New Standard of Care in the Treatment of Patients with Early Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) Trial HD10
    Mueller, R. P.
    Eich, H. T.
    Pluetschow, A.
    Debus, J.
    Bamberg, M.
    Wilbom, K.
    Eble, M.
    Mueller-Hennelink, H.
    Diehl, V.
    Engert, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S26 - S27
  • [39] Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease:: Long-term results of a randomized trial of radiotherapy alone
    Dühmke, E
    Franklin, J
    Pfreundschuh, M
    Sehlen, S
    Willich, N
    Rühl, U
    Müller, RP
    Lukas, P
    Atzinger, A
    Paulus, U
    Lathan, B
    Rüffer, U
    Sieber, M
    Wolf, J
    Engert, A
    Georgii, A
    Staar, S
    Herrmann, R
    Beykirch, M
    Kirchner, H
    Emminger, A
    Greil, R
    Fritsch, E
    Koch, P
    Drochtert, A
    Brosteanu, O
    Hasenclever, D
    Loeffler, M
    Diehl, V
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) : 2905 - 2914
  • [40] LONG TERM OUTCOME OF HIGH-DOSE SALVAGE THERAPY FOR PATIENTS WITH EARLY STAGE HODGKIN LYMPHOMA (HL) WHO FAILED INITIAL TREATMENT WITH COMBINED MODALITY TREATMENT OR CHEMOTHERAPY ALONE.
    Rimner, A.
    Lovie, S.
    Bonner, P.
    Hsu, M.
    Zhang, Z.
    Moskowitz, C. H.
    Yahalom, J.
    HAEMATOLOGICA, 2010, 95 : S25 - S26
12345